2024 Hematology News


April 2024

Presented by VJHemOnc: "The sequencing of CD19-targeting CAR-Ts and CD20-targeting bispecifices in DLBCL"

Want a comprehensive overview of the FDA-approved CD19 #CART products & CD20 bispecifics available for #DLBCL and an insight into their optimal sequencing? Watch the wonderful interview with (): 👉 ow.ly/YNcy50R7mwE


March 2024

CU Cancer Center Members Spotlight New Treatments for Relapsed Lymphomas

Manali Kamdar, MD, and Ajay Major, MD, MBA, published an educational review in conjunction with the American Society of Hematology annual meeting.



January 24. 2024

American Society of Clinical Oncology

HOT OFF THE PRESS 📰 Featured in #ASCODailyNews!! 📸  *Dr. Cassandra Duarte and Dr. Ajay Major* 📸

Understanding the Role of High-Dose Chemotherapy With ASCT Compared With CAR T-Cell Therapies in R/R LBCL



January 2024

Dr. Manali Kamdar was invited to chair the "How Do We Calibrate Cellular Therapy for Lymphoma in 2023?" Education Session @ the ASH 2023 Annual Meeting in San Diego, California.

She led the panel discussing cellular therapies such as CAR-T and bispecific antibodies. Important:

  • These novel therapies are used to treat aggressive relapsed non-Hodgkin lymphomas.
  • Anschutz Medical Campus is one of the only centers in this region of the United States to offer these novel therapies.
As part of the panel, Dr. Kamdar and Dr. Ajay Major published a review manuscript in Blooda high impact publication within the field of hematology that often sets the practice patterns for years.

Featured Media | Rocky Mountain Region | Anschutz Medical Campus

Dr. Dan Pollyea

 | 'Possibilities Endless' |

CU Hematology Logo

For appointments,

   for referrals,

      for consultations -

Hematology (SOM)

CU Anschutz

Research Complex II

12700 East 19th Avenue

Mail Stop B170

Aurora, CO 80045

Appointments: 720-848-6400

CMS Login